MPM Bioventures 2018, L.P., 10% Owner at iTeos Therapeutics, Inc. (ITOS), sold 48,277 shares at $27.06 ($1.3M) on 2021-10-04, disclosed to the SEC on 2021-10-05.
Scheduled sale ($1.3M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.00 | 6,855 | $185K | 14.2% |
| 2 | $27.06 | 20,711 | $560K | 42.9% |
| 3 | $27.06 | 20,711 | $560K | 42.9% |
| Total | $27.05 avg | 48,277 | $1.3M | 100% |
| Filing → |
| TRDA | SELL | 2026-08-31 | $616K | — | Filing → |
| TRDA | SELL | 2026-08-26 | $462K | — | Filing → |
| AKTS | BUY | 2026-01-14 | $20.0M | — | Filing → |